The rocky road to personalized medicine in acute myeloid leukaemia

Publisher： John Wiley & Sons Inc

E-ISSN： 1582-4934|22|3|1411-1427

ISSN： 1582-1838

Source： Journal of Cellular and Molecular Medicine, Vol.22, Iss.3, 2018-03, pp. : 1411-1427

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Monocytic myeloid‐derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 2, 2018-02 ,pp. : 1070-1080

John Wiley & Sons Inc

Access to resources Recommend Favorite

Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling

By  

Journal of Cellular and Molecular Medicine, Vol. 19, Iss. 7, 2015-07 ,pp. : 1742-1755

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome‐positive acute lymphoblastic leukaemia

By  

Journal of Cellular and Molecular Medicine, Vol. 22, Iss. 3, 2018-03 ,pp. : 1614-1626

John Wiley & Sons Inc

Access to resources Recommend Favorite

On the road: social change and celebration

By  

mailout.co, Vol. 2011, Iss. 2, 2011-04 ,pp. : 24-27

The Mailout Trust

Access to resources Recommend Favorite

Taking the Road Less Travelled

By Norman Natasha  

Third Text, Vol. 27, Iss. 3, 2013-05 ,pp. : 400-406

Routledge Ltd

Access to resources Recommend Favorite